Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality
Authors
Keywords
Hepatitis C virus, Hepatocellular carcinoma, Cirrhosis, Decompensated cirrhosis
Journal
BMC GASTROENTEROLOGY
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-08-07
DOI
10.1186/1471-230x-14-137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
- (2015) N. H. Afdhal et al. JOURNAL OF VIRAL HEPATITIS
- The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
- (2014) H. Razavi et al. JOURNAL OF VIRAL HEPATITIS
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis
- (2013) Soo Aleman et al. CLINICAL INFECTIOUS DISEASES
- Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis
- (2013) Esther J. Aspinall et al. CLINICAL INFECTIOUS DISEASES
- Emerging therapies for the treatment of hepatitis C
- (2013) Christian M Lange et al. EMBO Molecular Medicine
- A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care
- (2013) Christopher E. McGowan et al. HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011
- (2013) J. Iversen et al. JOURNAL OF VIRAL HEPATITIS
- Interferon free therapy with direct acting antivirals for HCV
- (2013) Tarik Asselah et al. LIVER INTERNATIONAL
- UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
- (2012) P. Ramachandran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas
- (2012) Antoine C. El Khoury et al. JOURNAL OF MEDICAL ECONOMICS
- Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis
- (2011) Ross J. Harris et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Hepatitis C and B testing in English prisons is low but increasing
- (2011) Patrick Kirwan et al. JOURNAL OF PUBLIC HEALTH
- Barriers to hepatitis C treatment
- (2011) Christopher E. McGowan et al. LIVER INTERNATIONAL
- A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus
- (2009) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo
- (2008) Mari A Bjornaas et al. BMC Psychiatry
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now